- ISIN
- US54300N1037
- CUSIP
- 54300N103
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Mar 12, 2021
Highlights
- Total Revenue (TTM)
- $8.00K
- Gross Profit (TTM)
- $4.00K
- EBITDA (TTM)
- -$87.45M
- Target Price
- $61.00
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
LBPH Performance Chart
Loading charts...
Returns By Period
Longboard Pharmaceuticals, Inc.
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
LBPH Monthly Returns History
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 252.24% | 4.43% | -2.61% | -1.39% | -11.41% | 43.24% | 22.97% | 8.54% | -7.62% | 79.18% | 0.44% | 0.00% | 894.69% |
| 2023 | 30.67% | 18.78% | -20.75% | 106.48% | -16.30% | 5.92% | -1.91% | -19.58% | -3.97% | -2.61% | -30.56% | 60.37% | 84.97% |
| 2022 | -13.93% | 9.29% | 16.34% | -9.50% | 6.36% | -39.88% | 8.74% | -0.30% | 11.04% | -0.54% | 45.14% | -39.29% | -33.20% |
| 2021 | -1.62% | -41.82% | -13.33% | 10.41% | -1.32% | 4.22% | -5.65% | -15.82% | -24.90% | -12.78% | -70.69% |
Benchmark Metrics
Longboard Pharmaceuticals, Inc. has an annualized alpha of 194.59%, beta of 0.49, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since March 15, 2021.
- This stock captured 253.36% of S&P 500 Index gains and 125.44% of its losses - amplifying both gains and losses, but participating more in upside than downside.
- Beta of 0.49 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 194.59%
- Beta
- 0.49
- R²
- 0.00
- Upside Capture
- 253.36%
- Downside Capture
- 125.44%
Return for Risk
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Longboard Pharmaceuticals, Inc. (LBPH) and compare them to S&P 500 Index.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Longboard Pharmaceuticals, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Longboard Pharmaceuticals, Inc. was 82.95%, occurring on Jul 1, 2022. Recovery took 377 trading sessions.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Bear market2022 | -82.95%Jul 2022 | 1y 2mo | 1y 6mo | 2y 9moApr 2021 - Jan 2024 |
2024 bear market2024 | -34.77%Apr 2024 | 2mo 24d | 2mo 12d | 5mo 6dJan 2024 - Jun 2024 |
2024 bear market2024 | -30.18%Sep 2024 | 2mo 2d | 27d | 2mo 29dJul 2024 - Oct 2024 |
2024 correction2024 | -10.76%Jan 2024 | 0s | 2d | 2dJan 2024 - Jan 2024 |
2024 correction2024 | -10.08%Jan 2024 | 2d | 13d | 15dJan 2024 - Jan 2024 |
Drawdown Indicators
| LBPH | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | — | -56.78% | — |
Max Drawdown (1Y)Largest decline over 1 year | — | -9.10% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | — | -0.74% | — |
Average DrawdownAverage peak-to-trough decline | — | -10.72% | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 1.97% | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Longboard Pharmaceuticals, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Longboard Pharmaceuticals, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with LBPH
Add Longboard Pharmaceuticals, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with LBPH